YCG
ALAB icon

Yeomans Consulting Group’s Astera Labs ALAB Stock Holding History

Yeomans Consulting Group’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,507
Closed -$488K – 135
2025
Q3 		$488K Buy
+2,507
New +$412K 0.17% 51

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Yeomans Consulting Group's ALAB Position: Q4 2025 in Review

Yeomans Consulting Group sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 2,507 shares — an estimated $488K sold.

Yeomans Consulting Group first reported a position in ALAB in Q3 2025 and held it in 1 quarter. The position peaked at $488K in Q3 2025. 700 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Yeomans Consulting Group reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
  • Yeomans Consulting Group sold 2,507 Astera Labs shares in Q4 2025, an estimated $488K.
  • Yeomans Consulting Group first reported a position in Astera Labs in Q3 2025 and held it in 1 quarter.
  • Yeomans Consulting Group's Astera Labs position peaked at $488K in Q3 2025.
  • 700 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Yeomans Consulting Group's 13F filing for Q4 2025, filed 7 Jan 2026.